While the potential of arginine deprivation therapy has been overshadowed by acquired resistance in cancer, our study describes a novel resistance mechanism by which EI24 sustains the arginine synthesis enzyme ASS1 through translational regulation and sheds light on the tumor-promoting function of EI24 with regard to cancer metabolism. The gene discussed is ASS1; the disease is cancer.